Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
37 /100
MEDIUM RISK
Score updated Aug 28, 2026

DRTS — Alpha Tau Medical Ltd. Dilution Risk Tracker

Track DRTS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DRTS — Get alerts when the score changes →

As of August 28, 2026, Alpha Tau Medical Ltd. (DRTS) has a DilutionWatch DilutionScore of 37/100, rated MEDIUM dilution risk. Alpha Tau Medical Ltd. has a market capitalization of $978.23M, 88.01M shares outstanding, 53 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $300.00M, 15.89M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
10
📊 Float Risk
50
⚠️ Warrant Exposure
50
🔄 Convertible Debt
40

Dilution Forecast

Watch
Minor dilution signals detected
model est. 18%
📜 Warrant Exercise model 25%
• Significant warrants: 18% of shares outstanding
💰 Capital Raise model 20%
• Active shelf registration ($300M, 31% of market cap)
🔔 Track DRTS — Get forecast alerts →

Market Data

Market Cap$978.23M
Shares Outstanding88.01M
Float47.48M
Cash$73.13M
Debt$5.25M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 92.6% shares (2026Q1 vs prior)
53 institutional holders · 4.46M shares
#1 HighTower Advisors, LLC 875.0K shares
#2 Aquamarine Financial (Cayman) Ltd 721.5K shares
#3 Apella Capital, LLC 382.3K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.21M
Days to Cover5.0
% of Float6.8%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2024-12-31
xbrl XBRL CONVERTIBLE 2022-12-31
EFFECT EFFECT 2026-05-01
F-3 SHELF 2026-04-28
3 FORM3 2026-03-18
Full SEC filing analysis available with free account

Recent News

No recent news

Factual DRTS Dilution Snapshot

Alpha Tau Medical Ltd. (DRTS) has a DilutionScore of 37/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track DRTS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking DRTS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for DRTS
DRTS FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.